We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSGS
501
DELISTED
CSG Systems International
CSGS
| $2.09M | 0.03% |
49,507
-2,320
| -4% | -$89.7K |
|
502
Tandem Diabetes Care
TNDM
$1.18B
| $2.08M | 0.03% |
32,794
-730
| -2% | -$38.3K |
|
|
PRSU
503
Pursuit Attractions and Hospitality Inc
PRSU
$1.46B
| $2.08M | 0.03% |
+36,897
| New | +$2M |
|
|
YELL
504
DELISTED
Yellow Corporation Common Stock
YELL
| $2.04M | 0.03% |
+304,425
| New | +$1.96M |
|
|
AKRX
505
DELISTED
Akorn Inc
AKRX
| $2.03M | 0.03% |
+577,782
| New | +$2.22M |
|
506
Cushman & Wakefield Ltd
CWK
$3.07B
| $2.02M | 0.03% |
+113,639
| New | +$1.96M |
|
|
ECOM
507
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.02M | 0.03% |
165,911
+40,300
| +32% | +$481K |
|
|
EXTN
508
DELISTED
Exterran Corporation
EXTN
| $2M | 0.03% |
118,816
+20,400
| +21% | +$363K |
|
|
QADA
509
DELISTED
QAD Inc.
QADA
| $1.95M | 0.03% |
45,367
+32,807
| +261% | +$1.41M |
|
510
Saia
SAIA
$11.2B
| $1.93M | 0.03% |
31,650
+650
| +2% | +$40.3K |
|
511
8x8 Inc
EGHT
$262M
| $1.93M | 0.03% |
95,400
-4,500
| -5% | -$87.9K |
|
|
UMPQ
512
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.93M | 0.03% |
+116,777
| New | +$2.06M |
|
|
BDN
513
Brandywine Realty Trust
BDN
$533M
| $1.92M | 0.03% |
121,315
-3,400
| -3% | -$51.4K |
|
514
Daktronics
DAKT
$956M
| $1.9M | 0.03% |
255,501
+17,000
| +7% | +$132K |
|
515
WaFd
WAFD
$2.69B
| $1.9M | 0.03% |
65,836
| – | – |
|
516
V2X
VVX
$2.73B
| $1.9M | 0.03% |
71,491
+12,909
| +22% | +$334K |
|
517
Sinclair Inc
SBGI
$974M
| $1.88M | 0.03% |
+48,916
| New | +$1.64M |
|
518
Powell Industries
POWL
$7.99B
| $1.88M | 0.03% |
212,214
+31,116
| +17% | +$306K |
|
519
Charles River Laboratories
CRL
$10.8B
| $1.87M | 0.03% |
12,876
-49,766
| -79% | -$6.54M |
|
520
Haverty Furniture Companies
HVT
$406M
| $1.87M | 0.03% |
85,328
-4,505
| -5% | -$97.3K |
|
|
THS
521
DELISTED
Treehouse Foods
THS
| $1.86M | 0.03% |
+28,890
| New | +$1.7M |
|
522
Valmont Industries
VMI
$9.61B
| $1.86M | 0.03% |
14,303
+570
| +4% | +$73.5K |
|
523
CRA International
CRAI
$1.12B
| $1.86M | 0.03% |
36,772
+4,967
| +16% | +$224K |
|
524
Radiant Logistics
RLGT
$415M
| $1.86M | 0.03% |
294,860
+17,600
| +6% | +$96.8K |
|
525
Prothena Corp
PRTA
$455M
| $1.85M | 0.03% |
152,488
+104,313
| +217% | +$1.3M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.